Interleukin-4 and Interleukin-17 are associated with coronary artery disease

Chenyang Wang1, Sheng Liu1, Yunxiao Yang1

  • 1Center for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Clinical Cardiology
|December 26, 2023
PubMed

Insights

Serum interleukin-4 (IL-4) and IL-17 levels are independent predictors of coronary artery disease (CAD). A model integrating these cytokines with clinical factors accurately identifies CAD patients.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Biomarker Discovery

Background:

  • Coronary artery disease (CAD) is a leading global cause of mortality.
  • Inflammatory factors are strongly associated with CAD development.
  • Predicting CAD incidence and distinguishing lesion presence is crucial.

Purpose of the Study:

  • To investigate the correlation between serum cytokine levels and CAD incidence.
  • To identify independent predictors of CAD.
  • To develop a predictive model for CAD diagnosis.

Main Methods:

  • Recruited 487 patients with suspected CAD (no acute myocardial infarction).
  • Measured serum levels of 12 cytokines using multiplexed flow cytometry.
  • Employed multivariate logistic regression and ROC curve analysis for prediction.

Main Results:

  • Serum levels of IL-4, IL-12p70, IL-17, IFN-α, and IFN-γ were lower in the CAD group.
  • IL-4 and IL-17 were identified as independent predictors of CAD.
  • A model combining IL-4, IL-17, HDL-C, sex, smoking, and diabetes showed strong predictive performance (AUC=0.826).

Conclusions:

  • Serum IL-4 and IL-17 are significant independent predictors of CAD.
  • A novel risk prediction model integrating cytokines and clinical factors can differentiate CAD patients.
  • This model aids in distinguishing CAD from suspected cases without acute myocardial infarction.
Abstract